By-Health Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2021
August 05, 2021 at 08:53 am EDT
Share
By-health Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 4,197.856 million compared to CNY 3,125.173 million a year ago. Operating income was CNY 1,639.859 million compared to CNY 1,255.448 million a year ago. Net income was CNY 1,371.139 million compared to CNY 961.836 million a year ago. Basic earnings per share from continuing operations was CNY 0.85 compared to CNY 0.61 a year ago. Diluted earnings per share from continuing operations was CNY 0.84 compared to CNY 0.61 a year ago.
Byhealth Co Ltd is a China-based company mainly engaged in the research, development, production and sales of dietary nutritional supplements. The Company's main products include glucosamine chondroitin vitamin D calcium tablets, natto red yeast and ginkgo leaf capsules, pueraria curcuma collagen tablets, donkey-hide gelatin angelica astragalus tablets, fish oil soft capsules, glucosamine chondroitin sulfate collagen peptide tablets and glucosamine chondroitin sulfate calcium tablets. The Company's main product categories include immune-boosting products, women's health products, bone health products and vitamins. The Company's products are mainly sold online and offline through brands such as By-Health, Jianliduo and Lifespace. The Company mainly conducts its businesses in domestic and overseas markets.